206 related articles for article (PubMed ID: 38392212)
1. Exploring the Functions of Mutant p53 through
Romashin D; Rusanov A; Arzumanian V; Varshaver A; Poverennaya E; Vakhrushev I; Netrusov A; Luzgina N
Curr Issues Mol Biol; 2024 Feb; 46(2):1451-1466. PubMed ID: 38392212
[TBL] [Abstract][Full Text] [Related]
2. Loss of mutant p53 in HaCaT keratinocytes promotes cadmium-induced keratin 17 expression and cell death.
Romashin D; Rusanov A; Tolstova T; Varshaver A; Netrusov A; Kozhin P; Luzgina N
Biochem Biophys Res Commun; 2024 May; 709():149834. PubMed ID: 38547608
[TBL] [Abstract][Full Text] [Related]
3. Impact of p53 knockdown on protein dataset of HaCaT cells.
Romashin DD; Rusanov AL; Kozhin PM; Karagyaur MN; Tikhonova OV; Zgoda VG; Luzgina NG
Data Brief; 2022 Jun; 42():108274. PubMed ID: 35647242
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features.
Benor G; Fuks G; Chin SF; Rueda OM; Mukherjee S; Arandkar S; Aylon Y; Caldas C; Domany E; Oren M
Mol Oncol; 2020 Aug; 14(8):1640-1652. PubMed ID: 32484602
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression.
Molès JP; Schiller JT; Tesniere A; Leigh IM; Guilhou JJ; Basset-Séguin N
J Cell Sci; 1994 Feb; 107 ( Pt 2)():435-41. PubMed ID: 7515894
[TBL] [Abstract][Full Text] [Related]
6. Wip1 regulates wound healing by affecting activities of keratinocytes and endothelial cells through ATM-p53 and mTOR signaling.
Yu N; Li T; Qiu Z; Xu J; Li Y; Huang J; Yang Y; Li Z; Long X; Zhang H
Burns; 2023 Dec; 49(8):1969-1982. PubMed ID: 37357059
[TBL] [Abstract][Full Text] [Related]
7. Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes.
Henseleit U; Zhang J; Wanner R; Haase I; Kolde G; Rosenbach T
J Invest Dermatol; 1997 Dec; 109(6):722-7. PubMed ID: 9406811
[TBL] [Abstract][Full Text] [Related]
8. Blocking mutation independent p53 aggregation by emodin modulates autophagic cell death pathway in lung cancer.
Haque E; Kamil M; Irfan S; Sheikh S; Hasan A; Nazir A; Mir SS
Int J Biochem Cell Biol; 2018 Mar; 96():90-95. PubMed ID: 29355754
[TBL] [Abstract][Full Text] [Related]
9. Role of p53 in regulation of hematopoiesis in health and disease.
Barajas S; Cai W; Liu Y
Curr Opin Hematol; 2022 Jul; 29(4):194-200. PubMed ID: 35787548
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis.
Pavlakis E; Neumann M; Merle N; Wieboldt R; Wanzel M; Ponath V; Pogge von Strandmann E; Elmshäuser S; Stiewe T
J Exp Clin Cancer Res; 2023 Aug; 42(1):203. PubMed ID: 37563605
[TBL] [Abstract][Full Text] [Related]
11. Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
Nakayama M; Sakai E; Echizen K; Yamada Y; Oshima H; Han TS; Ohki R; Fujii S; Ochiai A; Robine S; Voon DC; Tanaka T; Taketo MM; Oshima M
Oncogene; 2017 Oct; 36(42):5885-5896. PubMed ID: 28628120
[TBL] [Abstract][Full Text] [Related]
12. p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes.
Paramio JM; Segrelles C; Laín S; Gómez-Casero E; Lane DP; Lane EB; Jorcano JL
Mol Carcinog; 2000 Dec; 29(4):251-62. PubMed ID: 11170263
[TBL] [Abstract][Full Text] [Related]
13. TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.
Zhou G; Liu Z; Myers JN
J Cell Biochem; 2016 Dec; 117(12):2682-2692. PubMed ID: 27166782
[TBL] [Abstract][Full Text] [Related]
14. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression.
Kallassy M; Martel N; Damour O; Yamasaki H; Nakazawa H
Mol Carcinog; 1998 Jan; 21(1):26-36. PubMed ID: 9473769
[TBL] [Abstract][Full Text] [Related]
15. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
16. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
[TBL] [Abstract][Full Text] [Related]
17. Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.
Eun K; Park MG; Jeong YW; Jeong YI; Hyun SH; Hwang WS; Kim SH; Kim H
BMC Biotechnol; 2019 Jan; 19(1):1. PubMed ID: 30606176
[TBL] [Abstract][Full Text] [Related]
18. Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs.
Gerritsen M; Hilgendorf S; Yi G; Wierenga ATJ; Schuringa JJ; Martens JHA; Vellenga E
Exp Hematol; 2022 Jun; 110():39-46. PubMed ID: 35315319
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 as a Regulator and Target of Autophagy.
Shi Y; Norberg E; Vakifahmetoglu-Norberg H
Front Oncol; 2020; 10():607149. PubMed ID: 33614491
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors.
Fito-Lopez B; Salvadores M; Alvarez MM; Supek F
BMC Biol; 2023 Apr; 21(1):92. PubMed ID: 37095494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
